ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Carolina » Infectious Disease

Top Infectious Disease Prescribers in South Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PETER KWOFIE M.D.

Infectious Disease

16,931

$1.13M

549
322 are 65+

15%
patients receiving schedule two controlled substances

Avg: 2%

32%
patients receiving schedule three controlled substances

Avg: 3%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 62%

$66
Average prescription price

Avg: $459

JEHAD ABDALLA M.D.

Infectious Disease

7,561

$4.26M

213
46 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

12%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 62%

$564
Average prescription price

Avg: $459

AKINWALE OLATOSI M.B.B.S

Infectious Disease

7,048

$3.4M

266
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 62%

$482
Average prescription price

Avg: $459

JAMES CHARLES M.D.

Infectious Disease

4,421

$2.34M

132
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 62%

$530
Average prescription price

Avg: $459

JOHN GNANN MD

Infectious Disease

3,789

$1.42M

153
0 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

11%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 62%

$374
Average prescription price

Avg: $459

JOSEPH HORVATH M.D.

Infectious Disease

2,902

$1.8M

111
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 62%

$619
Average prescription price

Avg: $459

TIMOTHY WEST MD

Infectious Disease

2,509

$1.16M

94
33 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 62%

$464
Average prescription price

Avg: $459

DIVYA AHUJA MD

Infectious Disease

2,148

$1.5M

104
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

75%
prescriptions for brand name drugs

Avg: 62%

$698
Average prescription price

Avg: $459

JULIA HAILE MD

Infectious Disease

2,008

$1.06M

108
27 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 62%

$530
Average prescription price

Avg: $459

DAVID POTTS MD

Infectious Disease

1,848

$1.16M

72
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

21%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 62%

$629
Average prescription price

Avg: $459

DANNAH WRAY MD

Infectious Disease

1,788

$899K

47
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 62%

$503
Average prescription price

Avg: $459

JOHN SCHRANK M.D.

Infectious Disease

1,692

$1.1M

208
57 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 62%

$648
Average prescription price

Avg: $459

THEODORE GRIESHOP MD

Infectious Disease

1,612

$866K

126
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 62%

$537
Average prescription price

Avg: $459

TEMUJIN CHAVEZ M.D.

Infectious Disease

1,546

$1.1M

198
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 62%

$709
Average prescription price

Avg: $459

CHAMION OLIVIER MD

Infectious Disease

1,523

$868K

66
13 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 62%

$570
Average prescription price

Avg: $459

JUANMANUEL GOMEZ MD

Infectious Disease

1,445

$860K

40
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 62%

$595
Average prescription price

Avg: $459

KENT STOCK D.O.

Infectious Disease

1,267

$470K

230
126 are 65+

31%
patients receiving schedule two controlled substances

Avg: 2%

7%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 62%

$371
Average prescription price

Avg: $459

JOSEPH CANTEY MD

Infectious Disease

1,243

$655K

38
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 62%

$527
Average prescription price

Avg: $459

TERESA BOWERS M.D.

Infectious Disease

1,218

$776K

153
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 62%

$637
Average prescription price

Avg: $459

ARCHIBALD HAMPTON MD

Infectious Disease

1,186

$547K

86
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 62%

$461
Average prescription price

Avg: $459

SANGITA DASH M.D.

Infectious Disease

1,157

$945K

63
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

81%
prescriptions for brand name drugs

Avg: 62%

$817
Average prescription price

Avg: $459

CAMELIA MARCULESCU MD

Infectious Disease

1,157

$646K

66
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 62%

$558
Average prescription price

Avg: $459

STANLEY MILLER MD

Infectious Disease

1,127

$1.13M

92
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 62%

$1003
Average prescription price

Avg: $459

JOHN KELLY M.D.

Infectious Disease

1,097

$662K

145
35 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 62%

$604
Average prescription price

Avg: $459

WIN MYAT MD

Infectious Disease

1,091

$706K

65
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 62%

$647
Average prescription price

Avg: $459

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank